Skip to main content

Intensity Therapeutics, Inc 10-Q for FY2023 Q3

Intensity Therapeutics, Inc. (INTS)

10-Q 2023-11-13 For: 2023-09-30
View Original
Added on April 06, 2026

About this 10-Q

Intensity Therapeutics, Inc filed this 10-Q on November 13, 2023, covering the quarter ended September 30, 2023 (FY2023 Q3).

Headline figures

Quarter ended September 30, 2023, as reported in this filing, compared with the same period a year earlier where the filing states it.

Net loss
$2.33M
compared with a net loss of $1.77M a year earlier
Diluted EPS
-$0.17
compared with -$0.52 a year earlier